STRONG RESULTS: Pfizer Inc. posted sharply higher fourth-quarter net income as tight spending controls and a huge gain from selling its nutrition business helped offset sharply lower sales of cholesterol fighter Lipitor.
THE NUMBERS: Pfizer reported net income of $6.3 billion, or 85 cents a share. Revenue fell 7 percent at $15 billion, hurt by generic rivals to Lipitor and other prescription drugs.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.